AMETEK director granted 760 restricted shares
Stanage Nick L reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Stanage Nick L reported acquisition or exercise transactions in this Form 4 filing.
AMETEK director Nick L. Stanage received a grant of 760 shares of common stock as restricted stock. The award was issued on May 7, 2026 under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan at a reference value of $234.73 per share.
After this grant, Stanage directly holds 760 shares of AMETEK common stock reported in this filing. This is a compensation-related stock award rather than an open-market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 760 | $234.73 | $178K |
Footnotes (1)
- F1. Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.
Key Figures
Key Terms
restricted stock financial
2020 Omnibus Incentive Compensation Plan financial
Form 4 regulatory
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did AMETEK (AME) director Nick L. Stanage report in this Form 4?
Is Nick L. Stanage’s AMETEK (AME) Form 4 transaction an open-market purchase or sale?
What plan governed the restricted stock grant to AMETEK (AME) director Nick L. Stanage?
AI-generated analysis. How Rhea-AI works. Not financial advice.